Emerging data suggest Retatru tide , a dual stimulator targeting both incretin and glucose-dependent insulinotropic polypeptide , could represent a notable development for body loss . Preliminary human investigations have shown impressive reductions in abdominal fat , potentially surpassing existing weight-loss medications . However , more evaluati